Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Shares Outstanding (2018 - 2025)

TELA Bio (TELA) has 8 years of Shares Outstanding data on record, last reported at $40.3 million in Q3 2025.

  • For Q3 2025, Shares Outstanding rose 63.21% year-over-year to $40.3 million; the TTM value through Sep 2025 reached $40.3 million, up 63.21%, while the annual FY2024 figure was $39.4 million, 60.83% up from the prior year.
  • Shares Outstanding reached $40.3 million in Q3 2025 per TELA's latest filing, up from $39.6 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $40.3 million in Q3 2025 and bottomed at $14.4 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $23.7 million, with a median of $24.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: grew 0.41% in 2021, then skyrocketed 68.13% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $14.5 million in 2021, then skyrocketed by 31.9% to $19.2 million in 2022, then increased by 27.81% to $24.5 million in 2023, then soared by 60.83% to $39.4 million in 2024, then rose by 2.4% to $40.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $40.3 million in Q3 2025, $39.6 million in Q2 2025, and $39.6 million in Q1 2025.